Clinical Trial Update: Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone [Phase 3]

View source ↗

Summary

Phase 3 trial comparing montelukast to fluticasone for eosinophilic esophagitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysphagia
• Eosinophilic Esophagitis

Drugs mentioned

• Fluticasone (fluticasone propionate)
• Montelukast (Montelukast)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Eosinophilic Esophagitis, Dysphagia | Phase 3 | Status: WITHDRAWN